Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome

We hypothesized that sirolimus, an mTOR inhibitor, may be effective in patients with autoimmune lymphoproliferative syndrome (ALPS) and treated patients who were intolerant to or failed other therapies. Four patients were treated for autoimmune cytopenias; all had a rapid complete or near complete r...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Teachey, David T., Greiner, Robert, Seif, Alix, Attiyeh, Edward, Bleesing, Jack, Choi, John, Manno, Catherine, Rappaport, Eric, Schwabe, Dirk, Sheen, Cecilia, Sullivan, Kathleen E., Zhuang, Hongming, Wechsler, Daniel S., Grupp, Stephan A.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2009
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2819393/
https://ncbi.nlm.nih.gov/pubmed/19208097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07595.x
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة